Fariba Ghalamkarpour
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Fariba Ghalamkarpour has a total of 96 co-authors. Here are the top co-authors by number of shared publications:
- Fahimeh Abdollahimajd
Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
6 shared publications - Nasim Niknezhad
Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications - Mohammad Reza Pourani
Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
3 shared publications Nakisa Niknejad
Department of Pathology Hamedan University of Medical Sciences, Besat Hospital Hamedan Iran
3 shared publications- Reza Mahmoud Robati
Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
3 shared publications - Sahar Dadkhahfar
Skin Research Center Shahid Beheshti University of Medical Sciences Tehran Iran
3 shared publications
Latest Publications
- Open Access
- 8 July 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (7) , e70285
Evaluating the Association Between Acne Vulgaris and Diet: An Exploratory Study on Patient Beliefs and Perceptions
Background: Although there is content diversity, there are several data about the impact of diet on acne. However, studies about patients' beliefs about the effects of diet on acne are limited. So, in this study, we aimed to assess the perceptions and beliefs of patients about the association between acne and diet.Methods: It was a cross‐sectional study that was conducted on patients with a diagnosis of acne vulgaris in the dermatology clinic of Shohada Tajrish and Loghman Hakim Hospital (Tehran, Iran) from December 2022 to December 2023. A questionnaire was given to each patient, and basic data and beliefs of patients about the association between acne and diet were asked. All questionnaires were recorded in SPSS v.26 software and analyzed. A significant level was considered less than 0.05.Results: In this study, 793 patients participated in the study. 328 patients (41.36%) were 12–19 years old, and 482 of all patients (60.78%) were male. Most of the patients believed that sweets and chocolates and fatty and fried foods had negative impacts on acne and that fruits and vegetables, vitamins, and supplements (zinc, omega‐3, selenium, and green tea) improved the disease condition. Acne severity and skin type had significant relationships with the beliefs of patients about the effects of diet on acne (p‐values < 0.05).Conclusion: Although a considerable number of patients with acne believe that diet impacts acne, the patients should be educated about dietary habits that improve or aggravate the disease.
- 8 July 2025
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 24 (7) , e70285
Open AccessEvaluating the Association Between Acne Vulgaris and Diet: An Exploratory Study on Patient Beliefs and Perceptions
Background: Although there is content diversity, there are several data about the impact of diet on acne. However, studies about patients' beliefs about the effects of diet on acne are limited. So, in this study, we aimed to assess the perceptions and beliefs of patients about the association between acne and diet.Methods: It was a cross‐sectional study that was conducted on patients with a diagnosis of acne vulgaris in the dermatology clinic of Shohada Tajrish and Loghman Hakim Hospital (Tehran, Iran) from December 2022 to December 2023. A questionnaire was given to each patient, and basic data and beliefs of patients about the association between acne and diet were asked. All questionnaires were recorded in SPSS v.26 software and analyzed. A significant level was considered less than 0.05.Results: In this study, 793 patients participated in the study. 328 patients (41.36%) were 12–19 years old, and 482 of all patients (60.78%) were male. Most of the patients believed that sweets and chocolates and fatty and fried foods had negative impacts on acne and that fruits and vegetables, vitamins, and supplements (zinc, omega‐3, selenium, and green tea) improved the disease condition. Acne severity and skin type had significant relationships with the beliefs of patients about the effects of diet on acne (p‐values < 0.05).Conclusion: Although a considerable number of patients with acne believe that diet impacts acne, the patients should be educated about dietary habits that improve or aggravate the disease.
- Open Access
- 6 August 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (12) , 3968-3973
The effect of topical tranexamic acid with micro‐needling and micro‐needling alone in treatment of macular amyloidosis
Background: Macular amyloidosis is a form of primary localized cutaneous amyloidosis presented by pruritic pigmented macules in rippled or reticulate pattern. The aim of this study was to assess the efficacy of using topical tranexamic acid with micro‐needling comparing to micro‐needling alone in patients with macular amyloidosis.Materials and Methods: Patients with bilaterally located macular amyloidosis on trunk or upper extremities were recruited in this trial. The skin lesions in all patients were divided into two parts which were randomly assigned to the group of treatment with micro‐needling plus tranexamic acid and the group of micro‐needling alone. There were four sessions of treatment with 2 weeks interval. The percentage of improvement in pigmentation (based on photographs and dermoscopy) and rippling of each group was determined by three blinded dermatologists. The level of patient satisfaction and reduction of pruritus was measured by a questionnaire and defined as a percentage.Results: Twenty females were enrolled in this study. The mean (SD) patients' age was 39.7 (±10.13) years. Both groups showed improvement in pigmentation based on images, dermoscopy, and rippling pattern. Patients' satisfaction was 46.5% in tranexamic acid group and 47.5% in micro‐needling alone. Nevertheless, there was no significant difference between both groups (p value >0.05). Interestingly, the pruritus improved 61.66% after four sessions of treatment in both groups.Conclusion: Micro‐needling is a suitable modality for decreasing pruritus and pigmentation in macular amyloidosis. However, topical application of tranexamic acid does not lead to additional improvement.
- 6 August 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (12) , 3968-3973
Open AccessThe effect of topical tranexamic acid with micro‐needling and micro‐needling alone in treatment of macular amyloidosis
Background: Macular amyloidosis is a form of primary localized cutaneous amyloidosis presented by pruritic pigmented macules in rippled or reticulate pattern. The aim of this study was to assess the efficacy of using topical tranexamic acid with micro‐needling comparing to micro‐needling alone in patients with macular amyloidosis.Materials and Methods: Patients with bilaterally located macular amyloidosis on trunk or upper extremities were recruited in this trial. The skin lesions in all patients were divided into two parts which were randomly assigned to the group of treatment with micro‐needling plus tranexamic acid and the group of micro‐needling alone. There were four sessions of treatment with 2 weeks interval. The percentage of improvement in pigmentation (based on photographs and dermoscopy) and rippling of each group was determined by three blinded dermatologists. The level of patient satisfaction and reduction of pruritus was measured by a questionnaire and defined as a percentage.Results: Twenty females were enrolled in this study. The mean (SD) patients' age was 39.7 (±10.13) years. Both groups showed improvement in pigmentation based on images, dermoscopy, and rippling pattern. Patients' satisfaction was 46.5% in tranexamic acid group and 47.5% in micro‐needling alone. Nevertheless, there was no significant difference between both groups (p value >0.05). Interestingly, the pruritus improved 61.66% after four sessions of treatment in both groups.Conclusion: Micro‐needling is a suitable modality for decreasing pruritus and pigmentation in macular amyloidosis. However, topical application of tranexamic acid does not lead to additional improvement.
- Open Access
- 5 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9281
A rare case of cicatricial pemphigoid confined to the scalp with associated photodamage
Key Clinical Message: We present a case of Brunsting‐Perry characterized as an erythematous erosive plaque on photodamaged scalp skin, flaring after a recent prolonged sun exposure. Subsequent progression with blister formation led to the correct diagnosis, highlighting the need to consider cicatricial pemphigoid in eroded lesions without blisters, particularly on photodamaged skin.
- 5 August 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (8) , e9281
Open AccessA rare case of cicatricial pemphigoid confined to the scalp with associated photodamage
Key Clinical Message: We present a case of Brunsting‐Perry characterized as an erythematous erosive plaque on photodamaged scalp skin, flaring after a recent prolonged sun exposure. Subsequent progression with blister formation led to the correct diagnosis, highlighting the need to consider cicatricial pemphigoid in eroded lesions without blisters, particularly on photodamaged skin.
- Open Access
- 11 March 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (3) , e8646
Presentation of vitiligo in a case of COVID ‐19 infection concomitant with receiving remdesivir
Key Clinical Message: The occurrence of vitiligo following COVID‐19 infection and vaccination is well‐documented. The mitochondrial dysfunction of melanocytes in vitiligo and the potential impact of RDV on mitochondria raise concerns about RDV possibly causing vitiligo.
- 11 March 2024
- Published by Wiley in Clinical Case Reports
- Vol. 12 (3) , e8646
Open AccessPresentation of vitiligo in a case of COVID ‐19 infection concomitant with receiving remdesivir
Key Clinical Message: The occurrence of vitiligo following COVID‐19 infection and vaccination is well‐documented. The mitochondrial dysfunction of melanocytes in vitiligo and the potential impact of RDV on mitochondria raise concerns about RDV possibly causing vitiligo.
- Open Access
- 3 January 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (5) , 1808-1815
Comparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients
Introduction and Objectives: Vitiligo and alopecia areata (AA) are two autoimmune skin diseases that affect patients' quality of life (QoL) and give rise to psychosocial complications, such as depression, negative self‐image, less joyful social engagements, and low self‐esteem. These two disorders have common and uncommon characteristics. Therefore, in this study, we tried to evaluate the similarities and differences in the psychological parameters including quality of life, sleep disturbance, anxiety, and depression levels between, vitiligo and AA patients. Materials and Methods: Patients with either vitiligo or AA visiting the outpatient dermatology clinic from November 2017 to December 2020 have been included in this study. Persian versions of three questionnaires including the dermatology life quality index (DLQI), hospital anxiety and depression scale (HADS), and Pittsburgh sleep quality index (PSQI), have been used to assess the QoL, sleep disturbance, anxiety, and depression levels in patients. Results: In total, 188 patients, including 94 (50%) cases of AA and 94 (50%) patients with vitiligo, met the criteria. In AA patients, a significantly higher DLQI score was found ( p ‐value = 0.002) compared to the vitiligo cases, which means a better QoL in vitiligo patients. Additionally, AA patients had higher scores of anxiety (P‐valuep ‐Valuep ‐Value = 0.4888) was not significantly different between the two groups. Conclusions: Our data showed lower QoL and higher levels of anxiety and depression in AA patients compared to vitiligo cases, but no difference was seen in sleep disturbance in the PSQI‐P score.
- 3 January 2024
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (5) , 1808-1815
Open AccessComparing quality of life, anxiety, depression, sleep disturbance, and associated factors in vitiligo and alopecia areata patients
Introduction and Objectives: Vitiligo and alopecia areata (AA) are two autoimmune skin diseases that affect patients' quality of life (QoL) and give rise to psychosocial complications, such as depression, negative self‐image, less joyful social engagements, and low self‐esteem. These two disorders have common and uncommon characteristics. Therefore, in this study, we tried to evaluate the similarities and differences in the psychological parameters including quality of life, sleep disturbance, anxiety, and depression levels between, vitiligo and AA patients. Materials and Methods: Patients with either vitiligo or AA visiting the outpatient dermatology clinic from November 2017 to December 2020 have been included in this study. Persian versions of three questionnaires including the dermatology life quality index (DLQI), hospital anxiety and depression scale (HADS), and Pittsburgh sleep quality index (PSQI), have been used to assess the QoL, sleep disturbance, anxiety, and depression levels in patients. Results: In total, 188 patients, including 94 (50%) cases of AA and 94 (50%) patients with vitiligo, met the criteria. In AA patients, a significantly higher DLQI score was found ( p ‐value = 0.002) compared to the vitiligo cases, which means a better QoL in vitiligo patients. Additionally, AA patients had higher scores of anxiety (P‐valuep ‐Valuep ‐Value = 0.4888) was not significantly different between the two groups. Conclusions: Our data showed lower QoL and higher levels of anxiety and depression in AA patients compared to vitiligo cases, but no difference was seen in sleep disturbance in the PSQI‐P score.
- Open Access
- 6 November 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (3) , 1004-1008
Iranian psoriasis registry: Research protocol and preliminary results of a pilot study
Background: Psoriasis as a common cutaneous inflammatory disease affect many aspects of patients' life. Disease registries render it possible to collect valuable data regarding a disease prevalence and burden as well as long‐term observations concerning possible therapeutic regimens. Methods: This registry was designed for the ongoing systematic data collection on patients with psoriasis at two referral dermatology centers in Iran. The pilot phase of the registry was used to identify possible obstacles in the application and execution of systematic registration. Results: A total of 281 patients were registered with the mean age of 42.02 years. The disease duration was 12.06 ± 10.90 years with the variety of clinical presentations. There was no significant difference between males and females in the age of disease onset ( p = 0.53). Notably, 167 patients had children. Among them, 13 had children with psoriasis. The gender of the affected parent did not affect the possibility of psoriasis transmission to the child, and no significant difference was seen between the two sexes (P = 0.569). Regarding treatment, 99.4% of patients (n = 280) had used topical agents, 52.3% (n = 147) biologics, and 60.9% (n = 171) nonbiologic medications. Conclusion: Clinical trials report the efficacy and safety data regarding limited study populations in a restricted time window, and the results may differ from the general population. This highlights the importance of registry‐based studies for collecting and analyzing longitudinal information. In terms of long‐term disease complications such as malignancies, cardiovascular events, and serious adverse events, registry‐based studies will help clinicians better recognize and manage each disease.
- 6 November 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 23 (3) , 1004-1008
Open AccessIranian psoriasis registry: Research protocol and preliminary results of a pilot study
Background: Psoriasis as a common cutaneous inflammatory disease affect many aspects of patients' life. Disease registries render it possible to collect valuable data regarding a disease prevalence and burden as well as long‐term observations concerning possible therapeutic regimens. Methods: This registry was designed for the ongoing systematic data collection on patients with psoriasis at two referral dermatology centers in Iran. The pilot phase of the registry was used to identify possible obstacles in the application and execution of systematic registration. Results: A total of 281 patients were registered with the mean age of 42.02 years. The disease duration was 12.06 ± 10.90 years with the variety of clinical presentations. There was no significant difference between males and females in the age of disease onset ( p = 0.53). Notably, 167 patients had children. Among them, 13 had children with psoriasis. The gender of the affected parent did not affect the possibility of psoriasis transmission to the child, and no significant difference was seen between the two sexes (P = 0.569). Regarding treatment, 99.4% of patients (n = 280) had used topical agents, 52.3% (n = 147) biologics, and 60.9% (n = 171) nonbiologic medications. Conclusion: Clinical trials report the efficacy and safety data regarding limited study populations in a restricted time window, and the results may differ from the general population. This highlights the importance of registry‐based studies for collecting and analyzing longitudinal information. In terms of long‐term disease complications such as malignancies, cardiovascular events, and serious adverse events, registry‐based studies will help clinicians better recognize and manage each disease.
- Open Access
- 15 October 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (10) , e8065
Facial pyoderma gangrenosum associated with fallopian tube carcinosarcoma
Key Clinical Message: Pyoderma gangrenosum (PG) is a neutrophilic dermatosis associated with underlying disorders. The association between PG and solid organ tumors (SM), including gynecologic cancers, has been previously reported. Here, we report a case of a 61‐year‐old woman with pyoderma gangrenosum on the posterior auricular region associated with an underlying fallopian tube carcinosarcoma: a rare and aggressive gynecologic malignancy. The patient's ulcer responded favorably to treatment, and surgical resection of the tumor was performed. The patient was then referred for further cancer management. No new lesions or recurrences were found over the 18 months of routine follow‐up.
- 15 October 2023
- Published by Wiley in Clinical Case Reports
- Vol. 11 (10) , e8065
Open AccessFacial pyoderma gangrenosum associated with fallopian tube carcinosarcoma
Key Clinical Message: Pyoderma gangrenosum (PG) is a neutrophilic dermatosis associated with underlying disorders. The association between PG and solid organ tumors (SM), including gynecologic cancers, has been previously reported. Here, we report a case of a 61‐year‐old woman with pyoderma gangrenosum on the posterior auricular region associated with an underlying fallopian tube carcinosarcoma: a rare and aggressive gynecologic malignancy. The patient's ulcer responded favorably to treatment, and surgical resection of the tumor was performed. The patient was then referred for further cancer management. No new lesions or recurrences were found over the 18 months of routine follow‐up.
- Open Access
- 6 February 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (2) , 022001
Engineering organ-on-a-chip systems to model viral infections
Infectious diseases remain a public healthcare concern worldwide. Amidst the pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, increasing resources have been diverted to investigate therapeutics targeting the COVID-19 spike glycoprotein and to develop various classes of vaccines. Most of the current investigations employ two-dimensional (2D) cell culture and animal models. However, 2D culture negates the multicellular interactions and three-dimensional (3D) microenvironment, and animal models cannot mimic human physiology because of interspecies differences. On the other hand, organ-on-a-chip (OoC) devices introduce a game-changer to model viral infections in human tissues, facilitating high-throughput screening of antiviral therapeutics. In this context, this review provides an overview of the in vitro OoC-based modeling of viral infection, highlighting the strengths and challenges for the future.
- 6 February 2023
- Published by IOP Publishing in Biofabrication
- Vol. 15 (2) , 022001
Open AccessEngineering organ-on-a-chip systems to model viral infections
Infectious diseases remain a public healthcare concern worldwide. Amidst the pandemic of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 infection, increasing resources have been diverted to investigate therapeutics targeting the COVID-19 spike glycoprotein and to develop various classes of vaccines. Most of the current investigations employ two-dimensional (2D) cell culture and animal models. However, 2D culture negates the multicellular interactions and three-dimensional (3D) microenvironment, and animal models cannot mimic human physiology because of interspecies differences. On the other hand, organ-on-a-chip (OoC) devices introduce a game-changer to model viral infections in human tissues, facilitating high-throughput screening of antiviral therapeutics. In this context, this review provides an overview of the in vitro OoC-based modeling of viral infection, highlighting the strengths and challenges for the future.
- Open Access
- 1 January 2023
- Published by Wiley in Dermatologic Therapy
- Vol. 2023 (1)
Evaluation of E‐Cadherin Expression in Patients with Pemphigus Vulgaris via Immunohistochemistry
Pemphigus is a group of autoimmune bullous diseases that can affect the skin and mucous membranes, and it is vital to recognize the exact pathogenesis of this disease. This study aimed to investigate the role of E‐cadherin in the pathogenesis of pemphigus vulgaris (PV) and compare the expression of E‐cadherin in the lesions of PV patients with that in healthy individuals’ skin. Thirty tissue samples from histopathologically confirmed PV patients as the case group and 30 skin samples from healthy individuals as the control group were evaluated for E‐cadherin expression via the immunohistochemical method. Data analysis was performed using SPSS software version 25; chi‐squared and Fisher’s exact tests were used to examine the relationship between qualitative variables. Immunohistochemical staining revealed decreased E‐cadherin expression in the basal and suprabasal layers of the epidermis of PV patients compared with healthy individuals (P < 0.001). E‐cadherin expression was 1+ in 53.3% of patients, 2+ in 40% of patients, and 3+ in only one (3.3%) patient. On the other hand, the expression of E‐cadherin in other layers of the epidermis was 1+ in one patient, 2+ in five patients (25%), and 3+ in 14 patients (70%). Also, the expression of E‐cadherin in all layers of the epidermis was 3+ in all controls. E‐cadherin expression in the basal and suprabasal layers of the epidermis appears to be lower in patients with PV compared with controls. Therefore, E‐cadherin immunohistochemical staining helps diagnose PV along with other diagnostic methods. Moreover, these findings may shed light on the role of E‐cadherin as a potential target for disease treatment aiming at disease stabilization. However, more studies are needed to clarify this issue.
- 1 January 2023
- Published by Wiley in Dermatologic Therapy
- Vol. 2023 (1)
Open AccessEvaluation of E‐Cadherin Expression in Patients with Pemphigus Vulgaris via Immunohistochemistry
Pemphigus is a group of autoimmune bullous diseases that can affect the skin and mucous membranes, and it is vital to recognize the exact pathogenesis of this disease. This study aimed to investigate the role of E‐cadherin in the pathogenesis of pemphigus vulgaris (PV) and compare the expression of E‐cadherin in the lesions of PV patients with that in healthy individuals’ skin. Thirty tissue samples from histopathologically confirmed PV patients as the case group and 30 skin samples from healthy individuals as the control group were evaluated for E‐cadherin expression via the immunohistochemical method. Data analysis was performed using SPSS software version 25; chi‐squared and Fisher’s exact tests were used to examine the relationship between qualitative variables. Immunohistochemical staining revealed decreased E‐cadherin expression in the basal and suprabasal layers of the epidermis of PV patients compared with healthy individuals (P < 0.001). E‐cadherin expression was 1+ in 53.3% of patients, 2+ in 40% of patients, and 3+ in only one (3.3%) patient. On the other hand, the expression of E‐cadherin in other layers of the epidermis was 1+ in one patient, 2+ in five patients (25%), and 3+ in 14 patients (70%). Also, the expression of E‐cadherin in all layers of the epidermis was 3+ in all controls. E‐cadherin expression in the basal and suprabasal layers of the epidermis appears to be lower in patients with PV compared with controls. Therefore, E‐cadherin immunohistochemical staining helps diagnose PV along with other diagnostic methods. Moreover, these findings may shed light on the role of E‐cadherin as a potential target for disease treatment aiming at disease stabilization. However, more studies are needed to clarify this issue.
- Open Access
- 14 September 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (9) , e6346
Shared histological and immunohistological findings in two patients with generalized vitiligo associated with autoimmune atrophic gastritis
The prevalence of autoimmune atrophic gastritis (AAG) in vitiligo patients was estimated at about 15%. In both conditions, a release of specific antibodies and an autoimmune destruction of target cells (melanocytes in vitiligo, parietal cells (PC) in AAG) mediated by CD8‐T lymphocytes was demonstrated to perform a comparative histological study of vitiligo skin and AAG mucosa. In two patients with concomitant vitiligo and AAG, biopsies from the vitiligo lesions and gastric mucosa from corpus fundus were performed. Sections were immunostained with E‐cadherin, Coll IV, CD8, CD20, CD4 antibodies. The skin sections also were stained with HES, HMB45, MITF. Common histological findings were found in both diseases. Adhesivity impairment with down expression of E‐cadherin and Coll IV was objectivated. The protruding MITF+melanocytes and the detached PC were surrounded by an infiltrate including CD8 and CD4. CD8 was infiltrating the epidermis in close contact with the remaining melanocytes and the gastric glands around the remaining PC. In both diseases, the autoimmune process could be preceded by a detachment of either melanocytes in vitiligo or PC in AAG possibly in relation to an initial adhesivity impairment of these cells. Common autoimmune mechanisms could be suggested for both diseases.
- 14 September 2022
- Published by Wiley in Clinical Case Reports
- Vol. 10 (9) , e6346
Open AccessShared histological and immunohistological findings in two patients with generalized vitiligo associated with autoimmune atrophic gastritis
The prevalence of autoimmune atrophic gastritis (AAG) in vitiligo patients was estimated at about 15%. In both conditions, a release of specific antibodies and an autoimmune destruction of target cells (melanocytes in vitiligo, parietal cells (PC) in AAG) mediated by CD8‐T lymphocytes was demonstrated to perform a comparative histological study of vitiligo skin and AAG mucosa. In two patients with concomitant vitiligo and AAG, biopsies from the vitiligo lesions and gastric mucosa from corpus fundus were performed. Sections were immunostained with E‐cadherin, Coll IV, CD8, CD20, CD4 antibodies. The skin sections also were stained with HES, HMB45, MITF. Common histological findings were found in both diseases. Adhesivity impairment with down expression of E‐cadherin and Coll IV was objectivated. The protruding MITF+melanocytes and the detached PC were surrounded by an infiltrate including CD8 and CD4. CD8 was infiltrating the epidermis in close contact with the remaining melanocytes and the gastric glands around the remaining PC. In both diseases, the autoimmune process could be preceded by a detachment of either melanocytes in vitiligo or PC in AAG possibly in relation to an initial adhesivity impairment of these cells. Common autoimmune mechanisms could be suggested for both diseases.